Viruses in the pathogenesis of Kaposi's sarcoma - A review

Biochemical and Molecular Medicine

Volumn 58, Issue 1, 1996, Pages 1-12

  Kempf, W ^a   Adams, V ^b,c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; EPIDEMIOLOGICAL DATA; HERPES VIRUS; HISTOPATHOLOGY; HUMAN; KAPOSI SARCOMA; MALIGNANT TRANSFORMATION; REVIEW; SEXUALLY TRANSMITTED DISEASE; TUMOR IMMUNOLOGY; VIRUS INFECTION;

EID: 0030175945     PISSN: 10773150     EISSN: None     Source Type: Journal    
DOI: 10.1006/bmme.1996.0025     Document Type: Review

References (117)

1. 1. Kaposi M. Idiopathisches multiples Pigmentsarkom der Haut. Arch Dermatol Syphil 4:742-749, 1872.
2. 2. Reynolds WA, Winkleman RK, Soule EH. KS: A clinicopathologic study with particular reference to its relationship to the reticuloendothelial system. Medicine (Baltimore) 44:419-443, 1965.
3. 3. Digiovanna JJ, Safai B. Kaposi's sarcoma: Retrospective study of 90 cases with particular emphasis on the familial occurrence, ethnic background and prevalence of other diseases. Am J Med 71:779-783, 1981.
4. 4. Piette WW. The incidence of second malignancies in subsets of Kaposi's sarcoma. J Am Acad Dermatol 16:855-861, 1987.
5. 5. Taylor JF, Templeton AC, Vogel CL, et al. Kaposi's sarcoma in Uganda: A clinicopathological study. Int J Cancer 8:122-135, 1971.
6. 6. Templeton AC, Bhana D. Prognosis in KS. J Natl Cancer Inst 55:1301-1304, 1975.
7. 7. Olweny CLM. Epidemiology and clinical features of Kaposi's sarcoma in tropical Africa. In AIDS: The Epidemic of Kaposi's Sarcoma and Opportunistic Infections. (Friedman-Kien AE, Laubenstein LJ, Eds.). New York: Masson, 1984, pp. 35-40.
8. 8. Harwood AR, Osoba D, Hofstader SL, et al. Kaposi's sarcoma in recipients of renal transplants. Am J Med 67:759-765, 1979.
9. 9. Penn I. Kaposi's sarcoma in transplant patients. Report of 20 cases. Transplantation 27:8-11, 1979.
10. 10. Brooks JJ. Kaposi's sarcoma: A reversible hyperplasia. Lancet 2:1309-1311, 1986.
11. 11. Friedman-Kien AE, Laubstein L, Marmor M, et al. Kaposi's sarcoma and PCP among homosexual men-New York City and California. MMWR 30:305-307, 1981.
12. 12. Des Jarlais DC, Marmor M, Thomas P, Chamberland M, Zolla-Pazner S, Sencer DJ. Kaposi's sarcoma among four different AIDS risk groups. N Engl J Med 310:1119, 1984.
13. 13. Haverkos HW, Drotman DP, Morgan M. Prevalence of Kaposi's sarcoma among patients with AIDS. N Engl J Med 311:1518, 1985.
14. 14. Safai B, Johnson KG, Myskowski PL, et al. The natural history of Kaposi's sarcoma in acquired immunodeficiency syndrome. Ann Intern Med 103:744-750, 1985.
15. 15. Welch K, Finkbeiner W, Alpers CE, Blumenfeld W, Davis RL, Smuckler EA, Beckstead JH. Autopsy findings in the AIDS. J Am Med Assoc 252:1152-1159, 1984.
16. 16. Lemlich G, Schwamm L, Lebwohl M. Kaposi's sarcoma and acquired immunodeficiency syndrome. J Am Acad Dermatol 16:319-325, 1987.
17. 17. Friedman-Kien AE, Saltzman BR. Clinical manifestations of classical, endemic African, and epidemic AIDS-associated Kaposi's sarcoma. J Am Acad Dermatol 22:1237-1250, 1990.
18. 18. Masood R, Cai J, Law R, Gill P. AIDS-associated Kaposi's sarcoma pathogenesis, clinical features, and treatment. Curr Opin Oncol 5:831-834, 1993.
19. 19. Mitsuyasu RT. Clinical aspects of AIDS-related Kaposi's sarcoma. Curr Opin Oncol 5:835-844, 1993.
20. 20. Harris PJ. Treatment of Kaposi's sarcoma and other manifestations of AIDS with human chorionic gonadotropin. Lancet 346:118-119, 1995.
21. 21. Ackerman AB, Gottlieb GJ (Eds.). Atlas of the gross and microscopic features. In Kaposi's Sarcoma: A Text and Atlas. Philadelphia: Lea and Febiger, 1988 pp. 29-33.
22. 22. Beckstead JH, Wood GS, Fletcher V. Evidence for the origin of Kaposi's sarcoma from lymphatic endothelium. Am J Pathol 119:294-299, 1985.
23. 23. Stürzl M, Brandstetter H, Roth WK. Kaposi's sarcoma: A review of gene expression and ultrastructure of KS spindle cells in vivo. AIDS Res Hum Retroviruses 8:1753-1763, 1992.
24. 24. Center for Disease Control (CDC): Update: Acquired immunodeficiency syndrome - United States. MMWR 17-21, 1986.
25. 25. Beral V, Peterman TA, Berkelman RL, Jaffe HW. Kaposi's sarcoma among persons with AIDS: A sexually transmitted infection? Lancet 335:123-128, 1990.
26. 26. Beral V, Bull D, Darby S, Weller I, Carne C, Beecham M, Jaffe H. Risk of Kaposi's sarcoma and sexual practices associated with faecal contact in homosexual or bisexual men with AIDS. Lancet 339:632-635, 1992.
27. 27. Haverkos HW, Friedman-Kien AE, Drotman DP, Morgan WM. The changing incidence of Kaposi's sarcoma among patients with AIDS. J Am Acad Dermatol 22:1250-1253, 1990.
28. 28. Friedman-Kien AE, Saltzman BR, Cao Y, Nestor MS, Mirabile M, Li JJ, Peterman TA. Kaposi's sarcoma in HIV-negative homosexual men. Lancet 335:168-169, 1990.
29. 29. Mortimer PP. Viral cause of Kaposi's sarcoma? Lancet 1987.
30. 30. Pollack MS, Safai B, Myskowski PL, et al. Frequencies of HLA and GM immunogenetic markers in KS. Tissue Antigens 21:1-8, 1983.
31. 31. Qunibi W, Akthar M, Sheth Kirkant, et al. KS: The most common tumor after renal translantation in Saudi Arabia. Am J Med 84:225-232, 1988.
32. 32. Melbye M, Kestens L, Biggar RJ, et al. HLA studies of endemic African Kaposi's sarcoma patients and matched controls: No association with HLA-DR5. Int J Cancer 39:182-184, 1987.
33. 33. Smeraldi RS, Lazzarin A, Moroni M, et al. HLA-associated susceptibility to AIDS in Italian patients with HIV infection. Lancet 2:1187-1189, 1986.
34. 34. Gilles K, Louie L, Newman B, Crandall J, King MC. Genetic susceptibility to AIDS: Absence of an association with group-specific component (Gc). N Engl J Med 317:630-631, 1987.
35. 35. Harawi SJ. Kaposi's sarcoma. In Pathology and Pathophysiology of AIDS and HIV-Related Diseases (Harawi SJ, and O'Hara CJ (Eds.) London: Chapman and Hall Medical, 1990, pp. 83-133.
36. 36. Lunardi-Iskandar Y, Bryant JL, Zerman RA, Lam VH, Samaniego F, Besnier JM, Hermans P, Thierry AR, Gill P, Gallo RC. Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone. Nature 375:64-68, 1995.
37. 37. Bower M, Fife K, Nelson M, Youle M. Human chorionic gonadotropin for AIDS-related Kaposi's sarcoma (letter). Lancet 346:642, 1995.
38. 38. Von Overbeck J, Perey L, Iten A, Pechère M, Ruffieux P, Hirschl B. Human chorionic gonadotropin for AIDS-related Kaposi's sarcoma. Lancet 346:642-643, 1995.
39. 39. Safai B, Good AR. KS: A review and recent developments. Clin Bull 10:62-68, 1980.
40. 40. Leibovich SJ, Polverini PJ, Shepard HM, Wiseman DM, Shively V, Nuseir N. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature 329:630-632, 1987.
41. 41. Miles SA, Martinez-Maza O, Rezai A, Magpantay L, Kishimoto T, Nakamura S, Radka SF, Linsley PS. Oncostatin M as a potent mitogen for AIDS Kaposi's sarcoma-derived cells. Science 255:1432-1434, 1992.
42. 42. Li JJ, Huang YQ, Moscatelli D, Nicolaides A, Zhang WC, Friedman-Kien AE. Expression of fibroblast growth factors and their receptors in AIDS-associated Kaposi's sarcoma tissue and derived cells. Cancer 72:2253-2259, 1993.
43. 43. Sciacca FL, Stürzl M, Bussolino F, Sironi M, Brandstetter H, Zietz C, Zhou D, Matteucci C, Peri G, Sozzani S, Benelli R, Arese M, Albini A, Colotta F, Mantovani A. Expression of adhesion molecules, platelet-activating factor, and chemokines by Kaposi's sarcoma cells. J Immunol 153:4816-4825, 1994.
44. 44. (a) Naidu YM, Rosen EM, Zitnick R, Goldberg I, Park M, Naujokas M, Polverini PJ, Nickoloff BJ. Role of scatter factor in the pathogenesis of AIDS-related Kaposi's sarcoma. Proc Natl Acad Sci USA 91:5281-5285, 1994;
45. (b) Williams AO, Ward JM, Li JF, Lackson MA, Flanders KC. Immunohistochemical localization of transforming growth factor-β1 in Kaposi's sarcoma. Hum Pathol 26:469-473, 1995.
46. 45. Ensoli B, Nakamura S, Salahuddin SZ, Biberfeld P, Larsson L, Beaver B, Wong-Staal F, Gallo RC. AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science 243:223-226, 1989.
47. 46. Salahuddin SZ, Nakamura S, Biberfeld P, Kaplan MH, Markham PD, Larsson L, Gallo RC. Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro. Science 242:430-433, 1988.
48. 47. Ensoli B, Barillari G, Gallo RC. Pathogenesis of AIDS-associated Kaposi's sarcoma. Hematol Oncol Clin North Am 5:281-295, 1991.
49. 48. Werner S, Hofschneider PH, Roth WK. Cells derived from sporadic and AIDS-related Kaposi's sarcoma reveal identical cytochemical and molecular properties in vitro. Int J Cancer 43:1137-1144, 1989.
50. 49. Costa J, Rabson AS. Generalized Kaposi's sarcoma is not a neoplasm. Lancet 1:58, 1983.
51. 50. Sinkovics JG, Szakacs J, Györkey F. Multiple pathogens may induce growth factor cascade resulting in KS. In Drugs of Abuse, Immunity and AIDS (Friedman H, Klein TW, Spector S. Eds.). New York; Plenum, 1992.
52. 51. Stoler MH, Bonfiglio TA, Steigbigel RT, Pereira M. An atypical subcutaneous infection associated with acquired immune deficiency syndrome. Am J Clin Pathol 80:714-718, 1983.
53. 52. Cockerell CJ, Whitlow MA, Webster GF, Friedman-Kien AE. Epitheloid angiomatosis: A distinct vascular disorder in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Lancet 2:654-656, 1987.
54. 53. Giraldo G, Beth E, Huang ES. Kaposi's sarcoma and its relationship to cytomegalovirus (CMV) III. CMV DNA and CMV early antigens in Kaposi's sarcoma. Int J Cancer 26:23-29, 1980.
55. 54. Giraldo G, Buonaguro FM, Beth-Giraldo E. The role of opportunistic viruses in Kaposi's sarcoma (KS) evolution. APMIS Suppl. 8:62-76, 1989.
56. 55. Drew WL, Mintz L, Miner RC, Sands M, Ketterer B. Prevalence of cytomegalovirus infection in homosexual men. J Infect Dis 143:188-192, 1981.
57. 56. Mintz L, Drew WL, Miner RC, Braff EH. Cytomegalovirus infections in homosexual men. Ann Int Med 99:326-329, 1983.
58. 57. Handsfield HH, Chandler SH, Caine VA, et al. Cytomegalovirus infection in sex partners: Evidence for sexual transmission. J Infect Dis 151:344-348, 1985.
59. 58. Reichert C, O'Leary TJ, Levens DL, Simrell CR, Macher AM. Autopsy pathology in the acquired immune deficiency syndrome. Am J Pathol 112:357-382, 1984.
60. 59. Cerimele D, Scappaticci S, Cattaneo E, Cottoni F. Failure to demonstrate early and late antigens of cytomegalovirus in tissue cultures from Kaposi's sarcoma patients. Arch Dermatol Res 79:79-80, 1983.
61. 60. Civantos J, Penneys N, Ziegels-Weissman J. Kaposi's sarcoma: Immunoperoxidase staining for cytomegalovirus. AIDS Res 1(2):121-125, 1984.
62. 61. Delli-Bovi P, Donti E, Knowles DM II, Friedman-Kien A, Luciw PA, Dina D, Dalla-Favera R, Basilico C. Presence of chromosomal abnormalities and lack of AIDS retrovirus DNA sequences in AIDS-associated Kaposi's sarcoma. Cancer Res 46:6333-6338, 1986.
63. 62. Drew WL, Miner RC, Ziegler JL, Gulett JH, Abrams DI, Conant MA, Huang ES, Groundwater JR, Volberding P, Mintz L. Cytomegalovirus and Kaposi's sarcoma in young homosexual men. Lancet 125-127, 1982.
64. 63. Hashimoto H, Mueller H, Mueller F, Schmidts HL, Stutte HJ. In situ hybridization analysis of cytomegalovirus lytic infection in Kaposi's sarcoma associated with AIDS. A study of 14 autopsy cases. Virchows Arch A (Pathol Anat) 411:441-448, 1987.
65. 64. Grody WW, Lewin KJ, Naeim F. Detection of cytomegalovirus DNA in classic and epidemic Kaposi's sarcoma by in situ hybridization. Hum Pathol 19:524-529, 1988.
66. 65. Andersen CB, Karkov J, Bjerregaard B, Visfeldt J. Cytomegalovirus infection in classic, endemic and epidemic Kaposi's sarcoma analyzed by in situ hybridization. APMIS 99:893-897, 1991.
67. 66. Van den Berg F, Schipper M, Jiwa M, Rook R, Van de Rijke F, Tigges B. Implausibility of an aetiological association between cytomegalovirus and Kaposi's sarcoma shown by four techniques. J Clin Pathol 42:128-131, 1989.
68. 67. Kempf W, Adams V, Pfaltz M, Briner J, Schmid M, Moos R, Hassam S. Human herpesvirus type 6 and cytomegalovirus in AIDS-associated Kaposi's sarcoma: No evidence for an etiological association. Hum Pathol 26:914-919, 1995.
69. 68. Ambinder RF, Newman C, Hayward GS, Biggar R, Melbye M, Kestens L, Van Marck E, Piot P, Gigase P, Wright PB, Quinn TC. Lack of association of cytomegalovirus with endemic african Kaposi's sarcoma. J Inf Dis 156:193-197, 1987.
70. 69. Yamanishi K, Okuno T, Shiraki K, Takahashi M, Kondo T, et al. Identification of human herpesvirus-6 as causal agent for exanthema subitum. Lancet 1, 1065-1067, 1988.
71. 70. Berneman ZN, Ablashi DV. Molecular biology of human herpesvirus 6 (HHV-6). In Human Herpesvirus-6). In (Ablashi DV, Krueger GRF, Salahuddin SZ, Eds.) Amsterdam: Elsevier, 1992, Vol. 4, Chap. 8, 81-96.
72. 71. Cone RW, Hackman RC, Huang M-LW, Bowden RA, Meyers JD, Metcalf M, Zeh J, Ashley R, Corey L. Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation. N Engl J Med 329:156-161, 1993.
73. 72. Josephs SF, Ablashi DV, Salahuddin SZ. Molecular studies of HHV-6. J Virol Methods 21:179-190, 1988.
74. 73. Jahan N, Razzaque A, Greenspan J, Conant MA, Josephs SF, Nakamura S, Rosenthal LJ. Analysis of human KS biopsies and cloned cell lines for cytomegalovirus, HIV-1, and other selected DNA virus sequences. AIDS-RES-Hum-Retroviruses 5:225-231, 1989.
75. 74. Huang YQ, Li JJ, Rush MG, Poiesz BJ, Nicolaides A, Jacobson M, Zhang WG, Coutavas E, Abbott MA, Friedman-Kien AE. HPV-16-related DNA sequences in Kaposi's sarcoma. Lancet 339:515-518, 1992.
76. 75. Bovenzi P, Mirandola P, Secchiero P, Strumia R, Cassai E, Di Luca D. Human herpesvirus 6 (variant A) in Kaposi's sarcoma. Lancet 341:1288-1289, 1993.
77. 76. Corbellino M, Lusso P, Gallo RC, Paravicini C, Galli M, Moroni M. Disseminated human herpesvirus 6 infection in AIDS. Lancet 342:1242, 1993.
78. 77. Kehl-Knox K, Carrigan DR. Disseminated active HHV-6 infection in patients with AIDS. Lancet 343:577-578, 1994.
79. 78. Ueda K, Kusuhara K, Okada K, Miyazaki C, Hidaka K, Tokugawa K, Yamanishi K. Primary human herpesvirus 7 infection and exanthema subitum. Pediatr Infect Dis J 13:167-168, 1994.
80. 79. Portolani M, Cermelli C, Mirandola P, DiLucca D. Isolation of human herpesvirus 7 from an infant with febrile syndrome. J Med Virol 45:282-283, 1995.
81. 80. Frenkel N, Schrimer EC, Wyatt LS, Katsafanas G, Roffman E, Danovich RM, June CH. Isolation of a new herpesvirus from human CD4+ T cells. Proc Natl Acad Sci USA 87:748-752, 1990.
82. 81. Frenkel N, Wyatt LS. HHV-6 and HHV-7 as exogenous agents in human lymphocytes. Dev Biol Stand 76:259-265, 1992.
83. 82. Kempf W, Pfaltz M, Adams V, Hassam S, Moos R, Schmid M, Briner J. Nachweis von humanem Herpesvirus Typ 6 und 7, Zytomegalievirus und humanen Papilloma Viren in kutanen AIDS-assoziierten Kaposi-Sarkomen. Verh Dtsch Ges Pathol 78:260-264, 1994.
84. 83. Vousden KH. Human papillomaviruses and cervical carcinoma. Cancer Cells 1:43-50, 1989.
85. 84. Scinicariello F, Rady P, Cloyd MW, Tyring SK. HPV 18 in HIV-associated Kaposi's sarcoma. Lancet 337:501, 1991.
86. 85. Nickoloff BJ, Huang YQ, Li JJ, Friedman-Kien AE. Immunohistochemical detection of papillomavirus antigens in Kaposi's sarcoma. Lancet 339:548-549, 1992.
87. 86. Biggar RJ, Dunsmore N, Kurman RJ, Shah KV, Kordor J, Cottoni F, Hatzakis A, Gigase PL. Failure to detect human papillomavirus in Kaposi's sarcoma. Lancet 339:1604-1605, 1992.
88. 87. Adams V, Kempf W, Hassam S, Briner J, Schmid M, Moos R, Pfaltz M. Detection of several types of human papilloma viruses in AIDS-associated Kaposi's sarcoma. J Med Virol 46:189-193, 1995.
89. 88. Vogel J, Hinrichs SH, Reynolds RK, Luciw PA, Jay G. The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature 335:606-611, 1988.
90. 89. Ensoli B, Gendelman R, Markham P, Fiorelli V, Colombini S, Raffeld M, Cafaro A, Chang HK, Brady JN, Gallo RC. Synergy between basic fibroblast growth factor and HIV-1 tat protein in induction of Kaposi's sarcoma. Nature 371:674-680, 1994.
91. 90. Mahoney SE, Duvic M, Nickoloff BJ, Minshall M, Smith LC, Griffiths CE, Paddock SW, Lewis DE. Human immunodeficiency virus (HIV) transcripts identified in HIV-related psoriasis and Kaposi's sarcoma lesions. J Clin Invest 88:174-185, 1991.
92. 91. Rappersberger K, Tschachler E, Zonzits E, Gillitzer R, Hatzakis A, Kaloterakis A, Mann DL, Popow-Kraupp T, Biggar RJ, Berger R, Stratigos J, Wolff K, and Stingl G. Endemic Kaposi's sarcoma in human immunodeficiency virus type 1-seronegative persons: Demonstration of retrovirus-like particles in cutaneous lesions. J Invest Dermatol 95:371-381, 1990.
93. 92. Siddiqui A. Hepatitis B virus DNA in Kaposi's sarcoma. Proc Natl Acad Sci USA 80:4861-4864, 1983.
94. 93. Sinkovics JG. Kaposi's sarcoma: Its "oncogenes" and growth factors. Crit Rev Oncol Hematol 11:87-107, 1991.
95. 94. Lisitsyn N, Lisitsyn N, Wigler M. Cloning the differences between two complex genomes. Science 259:946-951, 1993.
96. 95. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865-1869, 1994.
97. 96. Cohen J. AIDS Mood upbeat - for a change. Science 267:959-960, 1995.
98. 97. Levy JA. A new human herpesvirus: KSHV or HHV8? Lancet 34:786, 1995.
99. 98. Ambroziak JA, Blackbourn DJ, Herndier BG, Glogau RG, Gullett JH, McDonald AR, Lennette ET, Levy JA. Herpeslike sequences in HIV-infected and uninfected Kaposi's sarcoma patients. Science 268:582-583, 1995.
100. 99. Dupin N, Grandadam M, Calvez V, Gorin I, Aubin JT, Havard S, Lamy F, Leibowitch M, Huraux JM. Escande JP, et al. Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma. Lancet 345:761-762, 1995.
101. 100. Huang YQ, Li JJ, Kaplan MH, Poiesz B, Katabira E, Zhang WC, Feiner D, Friedman-Kien AE. Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma. Lancet 345:759-761, 1995.
102. 101. Lebbé C, De Crémoux P, Rybojad M, Costa da Cunha C, Morel P, Calvo F. Kaposi's sarcoma and new herpesvirus. Lancet 345:1180, 1995.
103. 102. Moore PS, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N Engl J Med 332:1181-1185, 1995.
104. 103. Schalling M, Ekman M, Kaaya EE, Linde A, Biberfeld P. A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma. Nature Med 1:707-708, 1995.
105. 104. Whitby D, Howard MR, Tenant-Flowers M, Brink NS, Copas A, Boshoff C, Hattzioannou T, Suggett FEA, Aldam DM, Denton AS, Miller RF, Weller IVD, Weiss RA, Tedder RS, Schulz TF. Detection of Kaposi's sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 346:799-802, 1995.
106. 105. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332:1186-1191, 1995.
107. 106. Karcher DS, Alkan S. Herpes-like DNA sequences, AIDS-related tumors, and Castleman's disease. N Engl J Med 333:797-780, 1995.
108. 107. Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazales-Hatem D, Babinet P, d'Agay MF, Clauvel JP, Raphael M, Degos L. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86:1276-1280, 1995.
109. 108. Rady PL, Yen A, Rollefson JL, Orengo I, Bruce S, Hughes TK, Trying SK. Herpesvirus-like DNA sequences in non-Kaposi's sarcoma skin lesions of transplant patients. Lancet 345:1339-1340, 1995.
110. 109. Adams V, Kempf W, Schmid M, Müller B, Briner J, Burg G. Absence of herpesvirus-like DNA sequences in skin neoplasms of non-immunosuppressed patients. Lancet, 346:1715-1716, 1995.
111. 110. Gallo RC. Human retroviruses in the second decade: A personal perspective. Nature Med 1:753-759, 1995.
112. 111. Boshoff C, Schulz TF, Kennedy MM, Graham AK, Fisher C, Thomas A, McGee JO'D, Weiss RA, O'Leary JJ. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nature Med 1:1274-1278, 1995.
113. 112. Zur Hausen H. Viruses in human cancers. Science 254:1167-1173, 1991.
114. 113. Thompson J, Choudhury S, Kashanchi F, Doniger J, Berneman Z, Frenkel N, Rosenthal LJ. A transforming fragment within the direct repeat region of human herpesvirus type 6 that transactivates HIV-1. Oncogene 9:1167-1175, 1994.
115. 114. Guo WX, Antakly T. AIDS-related Kaposi's sarcoma: Evidence for direct stimulatory effect of glucocorticoid on cell proliferation. Am J Pathol 146:727-733, 1995.
116. 115. Jones J, Hanson DL, Chu SY, Ward JW, Jaffe HW. AIDS-associated Kaposi's sarcoma. Science 267:1078-1079, 1995.
117. 116. Costagliola D, Mary-Krause M. Can antiviral agents decrease the occurrence of Kaposi's sarcoma? Lancet 346:578, 1995.